Merit Medical Systems

Rank: 84
2015 Rank90
Employees3,754
Revenue:$542,149,000
R&D Spend:$40,810
Fiscal year ending:12-31-15
Click here to see all 100

Merit’s primary products consist of inflation devices used in angioplasty and stent placement; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; diagnostic and hydrophilic products used to manage and monitor the administration of contrast media and other fluid solutions; thrombolytic catheters and fluid dispensing systems; and embolotherapeutic products for the treatment of uterine fibroids, hypervascularised tumours, and arteriovenous malformations; and procedural trays, packs, and kits.

Merit Medical Announces 510(k) Clearance for Corvocet Biopsy System. Merit Medical Acquires the HeROGraft From CryoLife, Inc.

2015 Top 500 Solar Contractors Key Personnel: Fred Lampropoulos, Chairman & CEO; Bernard Birkett, CFO; Joe Wright, President, International Sales; Darla Gill, President, Merit Endotek; Ronald Frost, COO; Brian Lloyd; Chief Legal Officer; Justin Lampropoulos, EVP, Global Marketing; John Knorpp, Chief Regulatory Affairs Officer; Joseph Pierce, CIO; Louise Bott, VP, HR; Jason Treft, CTO;

1600 West Merit Parkway
South Jordan, Utah
84095
USA